Kelly Swinney

Kelly has over ten years of experience in the pharmaceutical industry working in the United States and Europe focused CMC activities spanning from pre-clinical development through marketing authorization. Kelly’s experience and expertise includes analytical chemistry, process analytical technology (PAT), solid state chemistry, pre-formulation development and small-scale, high throughput experimentation. Currently at Vertex, she leads the PAT group focused on process monitoring and real time release for continuous manufacturing. In this role, her team’s responsibilities include RTR strategy development, method development and validation, PAT technology development and implementation, and GMP manufacture support. Kelly holds a BS degree in Chemistry from James Madison University and a PhD in Chemistry from Texas Tech University. !--October 2013, MTB--)